4-n-Butoxy-3,5-difluorobenzaldehyde, 97.0%, 500mg

Imipramine hydrochloride, 95.0%, 1g

Allylsuccinic anhydride, 97.0%, 5g

(4-Acetylphenyl)(imino)(methyl)-l6-sulfanone, 500mg

3-(tert-Butyl)-5-iodobenzoic acid, 98%, 250mg

1-((1S,2S)-1-Hydroxy-1-(4-hydroxyphenyl)propan-2-yl)-4-phenylpiperidin-4-ol, 95.0%, 1mg

trans-Bis(acetato)bis[o-(di-o-tolylphosphino)benzyl]dipalladium(II)>95.0%(T)5g

1-Bromo-2-methoxy-5-methyl-3-nitrobenzene, 98%, 100mg

2-(3-Oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl)acetic acid, 95.0%, 5g

(3aR,3a'R,8aS,8a'S)-2,2'-(Cyclopropane-1,1-diyl)bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazole), 98.0%, 5g

1-Trifluoromethyl-cyclopentanecarboxylic acid, 95.0%, 25g

Lithium acetate dihydrate, min. 98%, 100 g, plastic packaging.

Ethyl 3-amino-6,6-dimethyl-5,6-dihydropyrrolo[3,4-c]pyrazole-1(4H)-carboxylate, 98%, 100mg